1. Home
  2. RNST vs XENE Comparison

RNST vs XENE Comparison

Compare RNST & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNST
  • XENE
  • Stock Information
  • Founded
  • RNST 1904
  • XENE 1996
  • Country
  • RNST United States
  • XENE Canada
  • Employees
  • RNST N/A
  • XENE N/A
  • Industry
  • RNST Major Banks
  • XENE Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNST Finance
  • XENE Health Care
  • Exchange
  • RNST Nasdaq
  • XENE Nasdaq
  • Market Cap
  • RNST 3.3B
  • XENE 3.2B
  • IPO Year
  • RNST N/A
  • XENE 2014
  • Fundamental
  • Price
  • RNST $35.95
  • XENE $43.87
  • Analyst Decision
  • RNST Strong Buy
  • XENE Strong Buy
  • Analyst Count
  • RNST 6
  • XENE 11
  • Target Price
  • RNST $43.17
  • XENE $53.55
  • AVG Volume (30 Days)
  • RNST 515.6K
  • XENE 782.5K
  • Earning Date
  • RNST 10-28-2025
  • XENE 11-03-2025
  • Dividend Yield
  • RNST 2.64%
  • XENE N/A
  • EPS Growth
  • RNST N/A
  • XENE N/A
  • EPS
  • RNST 1.84
  • XENE N/A
  • Revenue
  • RNST $775,309,000.00
  • XENE $7,500,000.00
  • Revenue This Year
  • RNST $43.22
  • XENE N/A
  • Revenue Next Year
  • RNST $12.94
  • XENE $207.88
  • P/E Ratio
  • RNST $19.44
  • XENE N/A
  • Revenue Growth
  • RNST 13.04
  • XENE N/A
  • 52 Week Low
  • RNST $26.97
  • XENE $26.74
  • 52 Week High
  • RNST $40.40
  • XENE $44.23
  • Technical
  • Relative Strength Index (RSI)
  • RNST 60.07
  • XENE 68.37
  • Support Level
  • RNST $33.16
  • XENE $39.09
  • Resistance Level
  • RNST $35.23
  • XENE $42.31
  • Average True Range (ATR)
  • RNST 0.80
  • XENE 1.48
  • MACD
  • RNST 0.23
  • XENE 0.31
  • Stochastic Oscillator
  • RNST 96.85
  • XENE 99.40

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: